Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing

ABSTRACT Background Oral mucositis affects about 20% of children undergoing high‐dose methotrexate (HDMTX) for acute lymphoblastic leukemia (ALL), despite existing management strategies. Personalized HDMTX dosing, adjusted by pharmacokinetics and leukemia risk, has reduced mucositis incidence, but v...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zhongbo Hu, Andrea M. Escalera‐Joy, Emily Ashcraft, Rushil Acharya, Sima Jeha, Cheng Cheng, Ching‐Hon Pui
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-11-01
Edice:	Cancer Medicine
Témata:	acute kidney injury acute lymphoblastic leukemia delayed methotrexate clearance high‐dose methotrexate oral mucositis risk factors
On-line přístup:	https://doi.org/10.1002/cam4.70351
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!